-
1
-
-
0042744849
-
The etiology, clinical presentation and management of pseudomyxoma peritonei
-
14567019 10.1016/S1055-3207(03)00026-7
-
Moran BJ, Cecil TD (2003) The etiology, clinical presentation and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 12:585-603
-
(2003)
Surg Oncol Clin N Am
, vol.12
, pp. 585-603
-
-
Moran, B.J.1
Cecil, T.D.2
-
2
-
-
0033386774
-
Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy
-
10622499 10.1007/s10434-999-0727-7 1:STN:280:DC%2BD3c%2Fos1aisw%3D%3D
-
Sugarbaker PH (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727-731
-
(1999)
Ann Surg Oncol
, vol.6
, pp. 727-731
-
-
Sugarbaker, P.H.1
-
3
-
-
29744469602
-
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
-
16389186 10.1016/S1470-2045(05)70539-8
-
Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7:69-76
-
(2006)
Lancet Oncol
, vol.7
, pp. 69-76
-
-
Sugarbaker, P.H.1
-
4
-
-
50849090661
-
Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)
-
18726894 10.1002/jso.21054
-
Moran B, Baratti D, Yan TD et al (2008) Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 98:277-282
-
(2008)
J Surg Oncol
, vol.98
, pp. 277-282
-
-
Moran, B.1
Baratti, D.2
Yan, T.D.3
-
5
-
-
0028797043
-
Peritonectomy procedures
-
7826158 10.1097/00000658-199501000-00004 1:STN:280:DyaK2M7is1OhsQ%3D%3D
-
Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29-42
-
(1995)
Ann Surg
, vol.221
, pp. 29-42
-
-
Sugarbaker, P.H.1
-
6
-
-
84864045941
-
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
-
22614976 10.1200/JCO.2011.39.7166
-
Chua TC, Moran B, Sugarbaker PH et al (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449-2456
-
(2012)
J Clin Oncol
, vol.30
, pp. 2449-2456
-
-
Chua, T.C.1
Moran, B.2
Sugarbaker, P.H.3
-
7
-
-
0030249797
-
Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin
-
8983281 10.1016/0959-8049(96)00178-5 1:STN:280:DyaK2s7gsFKnsA%3D%3D
-
Zoetmulder PA, Sugarbaker PH (1996) Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer 32A:1727-1733
-
(1996)
Eur J Cancer
, vol.32
, pp. 1727-1733
-
-
Zoetmulder, P.A.1
Sugarbaker, P.H.2
-
8
-
-
0029925562
-
Peritoneal carcinomatosis from appendiceal cancer: Paradigm for treatment of abdominopelvic dissemination of gastrointestinal malignancy
-
10.1007/BF02625947
-
Sugarbaker PH, Chang D, Koslowe P (1996) Peritoneal carcinomatosis from appendiceal cancer: paradigm for treatment of abdominopelvic dissemination of gastrointestinal malignancy. Acta Chir Austriaca 28:4-8
-
(1996)
Acta Chir Austriaca
, vol.28
, pp. 4-8
-
-
Sugarbaker, P.H.1
Chang, D.2
Koslowe, P.3
-
9
-
-
21244477557
-
Elevated tumor markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence
-
15932563 10.1111/j.1463-1318.2005.00773.x 1:STN:280: DC%2BD2M3oslOqtA%3D%3D
-
Alexander-Sefre A, Chandrakumaran K, Banerjee S et al (2005) Elevated tumor markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis 7:382-386
-
(2005)
Colorectal Dis
, vol.7
, pp. 382-386
-
-
Alexander-Sefre, A.1
Chandrakumaran, K.2
Banerjee, S.3
-
10
-
-
0036897471
-
Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy
-
12464587 10.1007/BF02574513
-
Van Ruth S, Hart AAM, Bonfrer JMG et al (2002) Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 9:961-967
-
(2002)
Ann Surg Oncol
, vol.9
, pp. 961-967
-
-
Van Ruth, S.1
Hart, A.A.M.2
Bonfrer, J.M.G.3
-
11
-
-
34547479234
-
Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
-
17510772 10.1245/s10434-007-9393-9
-
Baratti D, Kusamura S, Martinetti A et al (2007) Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 14:2300-2308
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 2300-2308
-
-
Baratti, D.1
Kusamura, S.2
Martinetti, A.3
-
12
-
-
77954908748
-
Clinical utility of elevated tumor markers in patients with disseminated appendiceal malignancies treated by cytoreductive surgery and HIPEC
-
20561764 10.1016/j.ejso.2010.05.024 1:STN:280:DC%2BC3cnovFKnsA%3D%3D
-
Ross A, Sardi A, Nieroda C et al (2010) Clinical utility of elevated tumor markers in patients with disseminated appendiceal malignancies treated by cytoreductive surgery and HIPEC. Eur J Surg Oncol 36:772-776
-
(2010)
Eur J Surg Oncol
, vol.36
, pp. 772-776
-
-
Ross, A.1
Sardi, A.2
Nieroda, C.3
-
13
-
-
18144406140
-
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer
-
15701175 10.1186/1477-7800-2-3
-
Harmon RL, Sugarbaker PH (2005) Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2:3
-
(2005)
Int Semin Surg Oncol
, vol.2
, pp. 3
-
-
Harmon, R.L.1
Sugarbaker, P.H.2
-
14
-
-
0028822980
-
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to pseudomyxoma peritonei
-
10.1097/00000478-199512000-00006
-
Ronnet BM, Zahn CM, Kurman RJ et al (1995) Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to pseudomyxoma peritonei. Am J Surg Pathol 19:1390-1408
-
(1995)
Am J Surg Pathol
, vol.19
, pp. 1390-1408
-
-
Ronnet, B.M.1
Zahn, C.M.2
Kurman, R.J.3
-
15
-
-
0042344950
-
Appendiceal mucinous neoplasms: A clinicopathologic analysis of 107 cases
-
12883241 10.1097/00000478-200308000-00006
-
Misdraji J, Yantiss RK, Graeme-Cook FM et al (2003) Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 27:1089-1103
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 1089-1103
-
-
Misdraji, J.1
Yantiss, R.K.2
Graeme-Cook, F.M.3
-
16
-
-
0000336139
-
Regression models and life tables (with discussion)
-
Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 34:187-220
-
(1972)
J R Stat Soc B
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
17
-
-
4444376038
-
Utility of CEA and CA19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix
-
15334630 10.1002/jso.20107
-
Carmignani CP, Hampton R, Sugarbaker CE et al (2004) Utility of CEA and CA19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol 87:162-166
-
(2004)
J Surg Oncol
, vol.87
, pp. 162-166
-
-
Carmignani, C.P.1
Hampton, R.2
Sugarbaker, C.E.3
-
18
-
-
84862607755
-
Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome
-
21853235 10.1007/s00384-011-1303-8
-
Chua TC, Liauw W, Morris DL (2012) Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis 27:381-389
-
(2012)
Int J Colorectal Dis
, vol.27
, pp. 381-389
-
-
Chua, T.C.1
Liauw, W.2
Morris, D.L.3
|